In recent years, immune-based treatments for cancer have buoyed the hopes of doctors and patients alike. Drugs called immune checkpoint inhibitors have provided lifesaving benefits to a growing list of people with several types of cancer, including melanoma, lung cancer, bladder cancer, and many more.
Despite the excitement surrounding these medications, a frustrating sticking point has been the inability of doctors to predict who will benefit from them and who will not.
On August 25, 2021, a group of researchers from Memorial Sloan Kettering Cancer Center reported in the journal Science Translational Medicine that a specific pattern, or signature, of markers on immune cells in the blood is a likely biomarker of response to checkpoint immunotherapy. Within this immune signature, a molecule LAG-3 provided key information identifying patients with poorer outcomes.
This link was discovered in a group of patients with metastatic melanoma and validated in a second group of patients with metastatic bladder cancer, suggesting that this potential biomarker may be broadly applicable to patients with a variety of cancers.
According to Margaret Callahan, an investigator with the Parker Institute for Cancer Immunotherapyat MSK and the physician-researcher who led the study, the large patient cohorts, robust clinical follow-up, and rigorous statistical approach of the study gives her enthusiasm that this immune signature is telling us something important about who responds to immunotherapy and why.
The findings pave the way for prospective clinical trials designed to test whether incorporating this biomarker into patient care can improve outcomes for those who are less likely to benefit from existing therapies.
Despite the excitement surrounding immune checkpoint inhibitors, a frustrating sticking point has been the inability of doctors to predict who will benefit from them and who will not.
In making their discoveries, the researchers had data on their side. As one of the first cancer centers in the world to begin treating large numbers of patients with immunotherapy, MSK has a cache of stored blood from hundreds of patients treated over the years, efforts pioneered by MSK researchers Jedd Wolchok and Phil Wong, co-authors on the study. The investigators of this study made their discoveries using pre-treatment blood samples collected from patients enrolled on seven different clinical trials open at MSK between 2011 and 2017.
To mine the blood for clues, researchers used a technique called flow cytometry. Flow cytometry is a tool that rapidly analyzes attributes of single cells as they flow past a laser. The investigators goal was to identify markers found on patients immune cells that correlated with their response to immunotherapy primarily PD-1 targeting drugs like nivolumab (Opdivo) and pembrolizumab (Keytruda). But this wasnt a job for ordinary human eyeballs.
When you think about the fact that there are hundreds of thousands of blood cells in a single patient blood sample, and that were mapping out the composition of nearly 100 different immune cell subsets, its a real challenge to extract clinically relevant information effectively, says Ronglai Shen, a statistician in the Department of Epidemiology and Biostatistics at MSK who developed some of the statistical tools used in the study. Thats where we as data scientists were able to help Dr. Callahan and the other physician-researchers on the study. It was a perfect marriage of skills.
The statistical tools that Dr. Shen and fellow data scientist Katherine Panageas developed allowed the team to sort patients into three characteristic immune signatures, or immunotypes, based on unique patterns of blood markers.
The immunotype that jumped out was a group of patients who had high levels of a protein called LAG-3 expressed on various T cell subsets. Patients with this LAG+ immunotype, the team found, had a much shorter survival time compared with patients with a LAG- immunotype: For melanoma patients, there was a difference in median survival of more than four years (22.2 months compared with 75.8 months) and the difference was statistically significant.
This immune signature is telling us something important about who responds to immunotherapy and why.
LAG-3 (short for lymphocyte-activation gene 3) belongs to a family of molecules called immune checkpoints. Like the more well-known checkpoints CTLA-4 and PD-1, LAG-3 has an inhibitory effect on immune responses, meaning it tamps them down. Several drugs targeting LAG-3 are currently in clinical development, although defining who may benefit from them the most has been challenging.
When Dr. Callahan and her colleagues started this research, they did not plan to focus on LAG-3 specifically. We let the data lead us and LAG-3 is what shook out, she says.
One strength of the study is its use of both a discovery set and a validation set. What this means is that the investigators performed their initial analysis on one set of blood samples from a large group of patients in this case, 188 patients with melanoma. Then, they asked whether the immune signature they identified in the discovery set could predict outcomes in an entirely different batch of patients 94 people with bladder cancer.
It could, and quite well.
When we looked at our validation cohort of bladder cancer patients who received checkpoint blockade, those who had the LAG+ immunotype had a 0% response rate, Dr. Callahan says. Zero. Not one of them responded. Thats compared with a 49% response rate among people who had the LAG- immunotype.
Because of the large data set, the scientists were also able to ask how their LAG+ immunotype compares with other known biomarkers of response specifically, PD-L1 status and tumor mutation burden. What they found was the immunotype provided new and independent information about patient outcomes, rather than just echoing these other biomarkers.
Biomarkers are important in cancer for several reasons. They may help clinicians and patients select the best treatment and may allow them to avoid unnecessary treatment or treatment that is unlikely to work.
Immunotherapy drugs are not without potential toxicity, Dr. Panageas says. So, if we can spare someone the potential risks of a treatment because we know theyre not likely to respond, thats a big advance.
The second reason is cost. Immunotherapy drugs are expensive, so having a means to better match patients with available drugs is vital.
And, because the researchers identified this biomarker using patient blood samples, it raises the pleasing prospect that patients could be assessed for this marker using a simple blood draw. Other biomarkers currently in use rely on tumor tissue typically obtained by a biopsy.
If I told you that you could have a simple blood draw and in a couple of days have information to make a decision about what therapy you get, Id say it doesnt get much better than that, Dr. Callahan says. Of course, there is still much work to be done before these research findings can be applied to patients in the clinic, but we are really enthusiastic about the potential to apply these findings.
A limitation of the study is that it is retrospective, meaning that the data that were analyzed came from blood samples that were collected years ago and stored in freezers. To confirm that the findings have the potential to benefit patients, investigators will need to test their hypothesis in a prospective study, meaning one where patients are enrolled on a clinical trial specifically designed to test the idea that using this immunotype in treatment decisions can improve patient outcomes.
What Im most excited about is prospectively evaluating the idea that not only can we identify patients who wont do as well with the traditional therapies but that we can also give these patients other treatments that might help them, based on our knowledge of what LAG-3 is doing biologically, Dr. Callahan says.
Read the rest here:
- Coatue Data Science Head Alex Izydorczyk Is Leaving the Company - Business Insider - November 25th, 2021
- Data Science Is a Key Weapon in the Fight Against Fraud - Built In - November 25th, 2021
- Grads from MIT, IITs, IIMs and other Renowned Varsities Working on Building LIVEY, a World-Class Data Science and AI-powered Healthcare Solution -... - November 25th, 2021
- Tim Kao: Infusing Data Science to Revolutionize the Functionalities of Navy and Marine Industries - Analytics Insight - November 25th, 2021
- COVID-19: Compliance to household mixing restrictions in England decreased with each lockdown - EurekAlert - November 25th, 2021
- Data science approaches to confronting the COVID-19 pandemic: a narrative review - DocWire News - November 25th, 2021
- Bayer and Microsoft partner to build new cloud-based digital tools - IT Brief New Zealand - November 25th, 2021
- Elizabeth Holmes testifies in Theranos trial & Athenahealth acquisition 2.0 - STAT - November 25th, 2021
- Who are the current generation of Chief Data Officers? - ComputerWeekly.com - November 25th, 2021
- Analysis in Government Awards 2021 Shortlist - GOV.UK - November 25th, 2021
- Pace receives NSF grant to expand data science instruction nationwide - Westfair Online - November 17th, 2021
- Snowflake Shapes the Future of Data Science with Python Support - Business Wire - November 17th, 2021
- UK Railroads Invest in Data Science, AI, and Machine Learning - Cities of the Future - November 17th, 2021
- Top Upcoming Data Science Webinars to Attend in 2021 - Analytics Insight - November 17th, 2021
- The Iconic CEO Erica Berchtold wants to use the science of data to convert you to online shopping - The Australian Financial Review - November 17th, 2021
- Immunosuppressants linked to severe reactions in people with common genetic profile - Stanford Medical Center Report - November 17th, 2021
- Why Genpact 'Dare in Reality' Is A Hackathon Not To Be Missed - Analytics India Magazine - November 17th, 2021
- TigerGraph expands its graph data library with 20 new algorithms - VentureBeat - November 17th, 2021
- Improving Your Odds of ML Success with MLOps - insideBIGDATA - November 17th, 2021
- Smarter Production and Data-Driven Insight | - Advanced Television - November 17th, 2021
- The Role of Women in Scalping up AI and Data Science - Analytics Insight - November 10th, 2021
- Debunking The Four Most Common Data Science Myths - Influencive - November 10th, 2021
- Olive Partners with ClosedLoop to Improve Care and Reduce Financial Risk for Patients - Yahoo Finance - November 10th, 2021
- Knowland Releases First-of-Its-Kind Future Event Activity Forecast - PRNewswire - November 10th, 2021
- The Question Weve Stopped Asking About Teen-Agers and Social Media - The New Yorker - November 10th, 2021
- Do You Want To Deploy Responsible AI In Your Organization? Join This Session To Operationalize Responsible AI - Analytics India Magazine - November 10th, 2021
- In-Demand skills research finds the US is one of the most competitive markets for skilled tech workers, but talent scarcity is a global issue -... - November 10th, 2021
- Data Science Master's Degree | 100% Online | University of ... - November 6th, 2021
- MSE in Data Science - November 6th, 2021
- Variable Names: Why They're a Mess and How to Clean Them Up - Built In - November 6th, 2021
- UVA Announces New Research Partnership at Intersection of Business and Data Science - UVA Today - November 6th, 2021
- Succeeding in Data Science Projects Inputs that Could Help You - Analytics Insight - November 6th, 2021
- Inspiring Innovation; New Short Talks Features Karl Schubert and Data Science Program - University of Arkansas Newswire - November 6th, 2021
- How to succeed around data science projects - Information Age - November 6th, 2021
- Training students at the intersection of power engineering and computer science WSU Insider - WSU News - November 6th, 2021
- California Tries to Close the Gap in Math, but Sets Off a Backlash - The New York Times - November 6th, 2021
- A look at some of the AI and ML expert speakers at the iMerit ML DataOps Summit - TechCrunch - November 6th, 2021
- Exploring, Monitoring and Modeling the Deep Ocean Are Goals of New Research - UT News - UT News | The University of Texas at Austin - November 6th, 2021
- UVA Science and Engineering Faculty Win 12 NSF Career Awards - University of Virginia - November 6th, 2021
- Microsoft Excel is still the data analytics gold standard. The pre-Black Friday sale can teach you fast. - The Next Web - November 6th, 2021
- Heard on the Street 10/28/2021 - insideBIGDATA - October 28th, 2021
- Insights on the Data Science Platform Global Market to 2027 - Featuring Microsoft, IBM and Google Among Others - Yahoo Finance - October 28th, 2021
- Ericsson helps Giga to map connectivity in more than a million schools - Ericsson - October 28th, 2021
- NIH awards nearly $75M to catalyze data science research in Africa - National Institutes of Health - October 26th, 2021
- Worldwide Data Science Platform Industry to 2027 - Increasing Adoption of Data-Driven Technologies by Enterprises Presents Opportunities - PRNewswire - October 26th, 2021
- Multi-institution project to train Kenyan experts to bring social determinants to bear on modeling health outcomes - Newswise - October 26th, 2021
- Takeda's Krista McKee on Shifting the Data Ecosystem - Bio-IT World - October 26th, 2021
- Stitch Fix CEO: 'Data science and algorithms are at the core' of the company - Oakland News Now - October 26th, 2021
- Miami Dade College to Host 10th Anniversary School of Science White Coat Ceremony and STEM Research Symposium - The Reporter - October 26th, 2021
- FDA takes hands-on approach to upskill workforce under data modernization action plan - Federal News Network - October 26th, 2021
- Global Data Science Platform Market (2021 to 2027) - by Component, Deployment, Organization Size, Function, Industry Vertical and Geography -... - October 26th, 2021
- Planning to study Data Science after Plus-Two? Heres what is on offer - Telegraph India - October 26th, 2021
- Consumer-facing Companies Still Have Few Incentives to Stop Data Breaches, and Thats a National Security Concern. - Council on Foreign Relations - October 26th, 2021
- Skills and online courses to become a Data Scientist, the top job role in the world by 2025 - India Today - October 26th, 2021
- Which degree is right for me: data science or digital health? - News - The University of Sydney - October 26th, 2021
- Data Science Leaders are Ruling the Corporate Industry for their Technical Talent as well as Management Expertise - Analytics Insight - October 26th, 2021
- Will Data Science be in Demand in the Future? - Entrepreneur - September 30th, 2021
- Promoting the Public Good | UVA Today - UVA Today - September 30th, 2021
- MetaCell launches innovative Cloud Hosting for life science and healthcare - Yahoo Finance - September 30th, 2021
- KDD 2021 Honors Recipients of the SIGKDD Best Paper Awards - Yahoo Finance - September 30th, 2021
- Analytics Insight Announces Big Data Analytics Companies of the Year - Yahoo Finance - September 30th, 2021
- R is better than Python. Try telling that to banks - eFinancialCareers - September 30th, 2021
- World AI & Data Science Conference to be held on October 13th, 2021 - Analytics Insight - September 27th, 2021
- How Data Science and Big Data are Shaping the Indian Food Industry in 2021? - Analytics Insight - September 27th, 2021
- mRNA Could Fight Diseases Such as Alzheimer's and Cancer, With Help of UVA Scientist - University of Virginia - September 27th, 2021
- Media advisory: Kevin Leicht to testify before congressional subcommittee about disinformation - University of Illinois News - September 27th, 2021
- Heard on the Street 9/27/2021 - insideBIGDATA - September 27th, 2021
- New Business Institute at UT Austin Will Specialize in Sports Analytics - Diverse: Issues in Higher Education - September 27th, 2021
- How AI is Transforming The Race Strategy Of Electric Vehicles - Analytics India Magazine - September 27th, 2021
- Argentine project analyzing how data science and artificial intelligence can help prevent the outbreak of Covid-19 | Chosen from more than 150... - September 25th, 2021
- Metropolitan Chicago Data-science Corps to partner with area organizations on projects - Northwestern University NewsCenter - September 25th, 2021
- Business of Sports Institute at UT McCombs School Founded by Gift from Accenture - UT News - UT News | The University of Texas at Austin - September 25th, 2021
- 'I Want The Folks in Our Society to Be Data Literate So That We Are Making Good Decisions Together for the Good of the World,' Says Professor... - September 25th, 2021
- Pandemic oversight board to preserve data analytics tools beyond its sunset date - Federal News Network - September 25th, 2021
- Increase the Readability of Your Python Script With 1 Simple Tool - Built In - September 25th, 2021
- On World Cancer Research Day, Illumina Highlights the Transformative Power of Genomics - Yahoo Finance - September 25th, 2021
- An Introduction to Portfolio Optimization in Python - Built In - September 25th, 2021
- Life sciences use of digital twins mirrors its application in other industries - MedCity News - September 25th, 2021
- The Top 3 Tools Every Data Scientist Needs - Built In - September 21st, 2021
- OpsRamp Introduces The Future of Incident Response: Harnessing Machine Learning and Data Science to Predict and Prevent IT Outages - Yahoo Finance - September 21st, 2021